Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Marketwatch
Thursday, September 25, 2014 - 8:58am
tags:
Boehringer Ingelheim, FDA, Spiriva, COPD
Valeant Shares Vault Higher, Boosting Allergan Bid Again
WSJ Online
Thursday, September 25, 2014 - 7:39am
tags:
Valeant Pharmaceuticals, M&A, Allergan
Novartis Says Psoriasis Drug Met End-Goal of Arthritis Studies
Bloomberg
Thursday, September 25, 2014 - 7:38am
tags:
Novartis, psoriasis, secukinumab, psoriatic arthritis
As Doctors Lose Clout, Drug Firms Redirect the Sales Call
WSJ Online
Thursday, September 25, 2014 - 7:37am
tags:
physicians, drug reps, formulary
Shire pays $56.5M to resolve whistleblower claims it improperly marketed drugs
Bizjournals.com
Wednesday, September 24, 2014 - 10:14pm
tags:
Shire, ADHD, False Claims Act, Adderall XR, Vyvanse, whistleblower lawsuits
Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency
Yahoo/Zacks.com
Wednesday, September 24, 2014 - 9:44pm
tags:
Novavax, vaccines, flu vaccine, H7N9, H7N9 VLP
Adaptimmune raises $104 mln to develop immune-system cancer drugs
Yahoo/Reuters
Wednesday, September 24, 2014 - 9:39pm
tags:
Adaptimmune, immuno-oncology
Gilead's New HIV Drug Key To Long-Term Strategy
Investors.com
Wednesday, September 24, 2014 - 6:43pm
tags:
Gilead Sciences, HIV, tenofovir
Pfizer will ask FDA to remove "black box" suicide warning from its anti-smoking medication
Yahoo/AP
Wednesday, September 24, 2014 - 6:41pm
tags:
Pfizer, Chantix, black box, FDA, smoking cessation
When It Comes To Its Reputation, The Pharmaceutical Industry Continues To Mess Up
Forbes
Wednesday, September 24, 2014 - 4:01pm
tags:
Physician Payment Sunshine Act, physician payments
GlaxoSmithKline set to name Philip Hampton as next chairman: report
First Word Pharma
Wednesday, September 24, 2014 - 11:26am
tags:
GSK
Zimmer and Biomet update on their mega-merger
Mass Device
Wednesday, September 24, 2014 - 11:25am
tags:
Zimmer, Biomet, M&A, devices
Acorda Rises Most Since 2011 on $525 Million Civitas Deal
Bloomberg
Wednesday, September 24, 2014 - 11:23am
tags:
Acorda, M&A, Parkinson's Disease, Civitas
Valeant offers olive branch to Allergan
Marketwatch
Wednesday, September 24, 2014 - 11:22am
tags:
Allergan, M&A, Bill Ackman, Valeant Pharmaceuticals
Anti-addiction groups call for new FDA chief
Yahoo/AP
Wednesday, September 24, 2014 - 9:49am
tags:
FDA, addiction, Margaret Hamburg
Acorda buys Civitas to gain access to Parkinson's drug
Yahoo/Reuters
Wednesday, September 24, 2014 - 9:48am
tags:
Acorda, Civitas, Parkinson's Disease, M&A, CVT-301
Lipocine testosterone therapy meets late-stage study goals
Yahoo/Reuters
Wednesday, September 24, 2014 - 9:37am
tags:
Lipocine, testosterone, LPCN 1021
FDA Fast Tracks MedImmune’s Pneumonia Drug
Drug Discovery and Development
Wednesday, September 24, 2014 - 9:03am
tags:
FDA, MedImmune, fast track, MEDI3902, AstraZeneca, nosocomial pneumonia
Biogen shoulders into gene therapy amid a second honeymoon for the field
Fierce Biotech
Wednesday, September 24, 2014 - 8:42am
tags:
Biogen Idec, gene therapy
Can copay coupons be kickbacks? HHS says yes
Fierce Pharma Marketing
Wednesday, September 24, 2014 - 8:40am
tags:
kickbacks, HHS, copay coupons

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.